Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Biron

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Antiviral Research|January 1, 1996
Pilot clinical trial of the combination of hydroxyurea and didanosine in HIV-1 infected individualsF Biron, F Lucht, D Peyramond, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|September 1, 1995
Anti-HIV activity of the combination of didanosine and hydroxyurea in HIV-1-infected individualsF Biron, F Lucht, D Peyramond, et al.
Medecine Et Maladies Infectieuses|November 8, 2005
[Treatment interruption in HIV infected patients: clinical and biological evolution]M Giard, A Boibieux, B Ponceau, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 25, 2015
Management of emerging multidrug-resistant tuberculosis in a low-prevalence settingG Catho, S Couraud, S Grard, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Antiviral Research|January 1, 1996
Pilot clinical trial of the combination of hydroxyurea and didanosine in HIV-1 infected individualsF Biron, F Lucht, D Peyramond, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|September 1, 1995
Anti-HIV activity of the combination of didanosine and hydroxyurea in HIV-1-infected individualsF Biron, F Lucht, D Peyramond, et al.
Medecine Et Maladies Infectieuses|November 8, 2005
[Treatment interruption in HIV infected patients: clinical and biological evolution]M Giard, A Boibieux, B Ponceau, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 25, 2015
Management of emerging multidrug-resistant tuberculosis in a low-prevalence settingG Catho, S Couraud, S Grard, et al.
Pageof 6